Journal of Nuclear Medicine: 56 (8)

August 1, 2015; Volume 56,Issue 8

Cover image

Skeletal tumor burden on baseline fluoride PET/CT has been shown to be a predictive biomarker of survival and skeleton-related events in patients treated with ²²³Ra. See page 1177.

In this issue

Issue highlights

The Value of Establishing the Quantitative Accuracy of PET/CT Imaging
Repeatability of ¹⁸F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
Fetal Radiation Dose from ¹⁸F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR
Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying

Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with ¹⁷⁷Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
⁶⁸Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the ⁶⁸Ga-FAPI PET Prospective Observational Trial

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to